Ethyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate, 95.0%, 1g

Matraces aforados clase B transparente, 100 ml, 14/23, 2 Pieza(s)

3-Acetoxy-4'-ethoxybenzophenone, 90.0%, 1g

(5-Methyl-1,3-thiazol-2-yl)methanol, 97.0%, 25g

Methyl 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)acetate, 95.0%, 250mg

1-METHYL-4-(2-(3-NITROPHENYL)HYDRAZONO)PIPERIDINE, 97.0%, 1g

4-AMINO-3-FLUORO-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER, 95.0%, 500mg

(R)-1-(2-Chloro-6-fluorophenyl)ethanol, 97%, 1g

N-[(1R,2R)-1-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-1-HYDROXY-3-PYRROLIDIN-1-YLPROPAN-2-YL]OCTANAMIDE, 95%, 100mg

2,3,6,7,10,11-Hexamethoxytriphenylene>95.0%(HPLC)1g

1-(6-Amino-3,3-dimethylindolin-1-yl)ethanone, 95.0%, 10g

trans-4-Phenylcyclohexaneacetic acid, 95%, 250mg

tert-Butyl (2-(2-(2-(2-iodoethoxy)ethoxy)ethoxy)ethyl)carbamate, 100mg